Innovative custom antibody production enables researchers to unlock research potential and gain a competitive edge. The quality or availability of catalog antibodies can be limiting factors, and custom antibodies enable the generation of novel, complex, or unusual antibodies that cannot be produced using standard methods. This approach opens the door to securing IP rights, facilitating important collaborations with pharmaceutical and biotech companies, and accelerating the pace of new advances in life science.
Our experienced scientists can provide expert guidance throughout all stages of the process, from vector design to cell bank creation. We offer a one-stop solution, and a dedicated project manager will handle your order from start to finish. We specialize in high-quality antibodies for a range of applications, including flow cytometry, immunochemistry, and pharmacology.
Innovative Custom Antibody Production: Advancing Research and Applications
We offer both monoclonal and polyclonal antibody generation. Choosing the best option depends on your project requirements. For early exploratory projects that require only small amounts of reagent up front, polyclonal antibody production can be the most cost-effective. For more advanced assays that need higher levels of reagent, monoclonal generation may be the best choice.
The monoclonal antibody (mAb) segment held a dominant position in the market in 2023. This was largely due to the critical medical applications of mAbs in diagnostics and therapy. In addition, advancements in biotechnology and genetic engineering have boosted the efficiency of the antibody production process. This has subsequently led to shorter delivery timelines.